Article
Yeast-derived glycolipids disrupt Candida biofilm and inhibit expression of genes in cell adhesion
1 Jul 2025
Abstract excerpt
Candida albicans is a leading fungal pathogen in humans, responsible for infections that span from mucosal surfaces to severe systemic diseases. This study aimed to investigate potential ability of yeast-derived glycolipids from Meyerozyma guilliermondii as an antifungal against Candida albicans biofilms. Glycolipid extract (64 µg/mL) reduced metabolic activity by 50% in both immature and mature biofilms, while...
Topics
Join the communities discussing this publication.
